Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$28.34 - $33.63 $42.8 Million - $50.8 Million
-1,509,196 Reduced 54.64%
1,252,953 $39.2 Million
Q1 2023

May 15, 2023

BUY
$25.31 - $29.02 $3.05 Million - $3.5 Million
120,573 Added 4.56%
2,762,149 $77.9 Million
Q4 2022

Feb 14, 2023

BUY
$21.94 - $26.24 $4.49 Million - $5.36 Million
204,439 Added 8.39%
2,641,576 $69 Million
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $10.6 Million - $15.3 Million
481,630 Added 24.63%
2,437,137 $54.4 Million
Q2 2022

Aug 15, 2022

SELL
$26.4 - $30.54 $16.3 Million - $18.9 Million
-618,017 Reduced 24.01%
1,955,507 $58.3 Million
Q1 2022

May 16, 2022

SELL
$23.07 - $27.99 $9.03 Million - $11 Million
-391,268 Reduced 13.2%
2,573,524 $67.7 Million
Q4 2021

Feb 14, 2022

BUY
$21.47 - $32.08 $8.8 Million - $13.1 Million
409,816 Added 16.04%
2,964,792 $69 Million
Q3 2021

Nov 15, 2021

BUY
$23.37 - $32.13 $8.13 Million - $11.2 Million
347,979 Added 15.77%
2,554,976 $78.8 Million
Q2 2021

Aug 16, 2021

BUY
$18.78 - $25.15 $41.4 Million - $55.5 Million
2,206,997 New
2,206,997 $54.1 Million
Q2 2018

Aug 14, 2018

SELL
$40.56 - $51.36 $157,291 - $199,174
-3,878 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$53.61 - $67.26 $703,255 - $882,316
-13,118 Reduced 77.18%
3,878 $225,000
Q4 2017

Feb 14, 2018

BUY
$47.69 - $55.39 $810,539 - $941,408
16,996
16,996 $930,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.22B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.